A study by Gide et al. performed transcriptomic analysis of tumour-infiltrating T cells in tumour biopsies of melanoma patients and revealed that an effector T-cell phenotype overexpressing EOMES, CD69, and CD45RO is a feature of responders [61]. The gene discussed is CD69; the disease is neoplasm.